The winners and losers of Biden's plans to expand coverage of…
Weight-loss drugs will impact the healthcare value chain faster if coverage is expanded
Spiralling obesity costs could be solved by Ozempic and other weight-loss drugs
Tipping the scales: the economic case for weight loss drugs is strong, but there are issues to consider
